Quarterly report pursuant to Section 13 or 15(d)

Schedule of Deferred Financing Cost Balance (Details)

v3.7.0.1
Schedule of Deferred Financing Cost Balance (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2017
Debt Instrument [Line Items]      
Balance as of January 1, 2017, net   $ 927,085 $ 927,085
Additions - revolving credit facility $ 1,200,000 1,223,359  
Debt discount amortization expense     (65,612)
Balance as of June 30, 2017, net 2,770,144   2,770,144
Revolving Credit Facility [Member]      
Debt Instrument [Line Items]      
Balance as of January 1, 2017, net   $ 927,085 927,085
Additions - revolving credit facility [1]     2,277,024
Debt discount amortization expense     (433,965)
Balance as of June 30, 2017, net $ 2,770,144   $ 2,770,144
[1] This amount includes $1,223,359 of costs incurred in connection with the Company’s amended revolving credit facility that were erroneously expensed and included in the General and Administrative line item within the Company’s Consolidated Statement of Operations for the three months ended March 31, 2017. During the six-month period ended June 30, 2017, the Company corrected this immaterial misstatement by removing the $1,223,359 from expense and capitalizing it as deferred financing costs on the Company’s Consolidated Balance Sheet as of June 30, 2017. See Note 2 – “Summary of Significant Accounting Policies.”